A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Stevens-Johnson syndrome (SJS) and its severe form, toxic epidermal necrolysis (TEN), are rare but life-threatening cutaneous adverse reactions to drugs, especially to allopurinol, carbamazepine, lamotrigine, phenobarbital, phenytoine, sulfamethoxazole, oxicam and nevirapine. Recently, a strong association between carbamazepine and allopurinol induced SJS or TEN has been described with respectively, HLA-B*1502 and HLA-B*5801 in a Han Chinese population from Taiwan and other Asian countries. OBJECTIVE: The objective is to further investigate the relationship between SJS/TEN and HLA-B in a large number of patients in a European population. METHODS: HLA-B genotyping was performed on 150 patients included in a European study (RegiSCAR) of SJS and TEN. We focused on patients related to 'high-risk' drugs including: 31 cases related to allopurinol, 28 to sulfamethoxazole, 19 to lamotrigine and 14 to oxicam. RESULTS: Sixty-one percent of 31 allopurinol-induced SJS/TEN patients carried the HLA-B*5801 allele and the figure was 55% for 27 patients of European ancestry [odds ratio=80 (34-187)], (P<10(-6)) as previously observed in Han Chinese. For other drugs, two rare alleles showed a weaker association with SJS/TEN in a limited number of patients: B*38 for sulfamethoxazole or lamotrigine-related patients, and B*73 for oxicam. CONCLUSION: At variance with prior results in Asia, this study shows that even when HLA-B alleles behave as strong risk factors, as for allopurinol, they are neither sufficient nor necessary to explain the disease. Further investigations are necessary to delineate the exact role of the HLA region in SJS/TEN, and to look for other associations in other regions of the genome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, several studies have found that HLA-B*58:01, which was expressed relatively more frequently in the Chinese population (10–15%) compared to the Caucasian population (0.8%) is strongly associated with allopurinol sensitivity and cause Stevens–Johnson Syndrome [104].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [104]
In the citing paper
“Furthermore, several studies have found that HLA-B*58:01, which was expressed relatively more frequently in the Chinese population (10–15%) compared to the Caucasian population (0.8%) is strongly associated with allopurinol sensitivity and cause Stevens–Johnson Syndrome [104].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [104]
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807 · cited 1×
“Adverse reactions to drugs are important causes of morbidity and even of death in developed countries [ 1 ].”
BackgroundA marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Self-citationMallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380 · cited 1×
“In the previous years growing interest focused on the role of HLA in severe drug reactions, which was initiated by the demonstration that HLA-B*5701, was strongly associated with hypersensitivity to the anti-HIV medication abacavir [ 16 ,17].”
BackgroundHLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284 · cited 4×
“In Taiwan the carrier prevalence of B*5801 was 20% in a control group [ 21 ].”
BackgroundInfluentialMockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
Self-citationInhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005 · cited 1×
“The initial events triggering the immune reaction remain to be identified [ 10 ].”
BackgroundInhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
Delayed Drug Hypersensitivity Reactions
Pichler, W. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00012 · Cited by 735
Cited by
Items 501–600 of 660
SJS/TEN Overlap Associated with Lomefloxacin: Case Report and Molecular Typing Studies
Lonati, D., Zancan, A., Pasi, A., Schreiber, A. F., Giampreti, A., Pignatti, P., Stella, M., Locatelli, C., Manzo, L., & Martinetti, M. (2014) · Dermatology · doi:10.1159/000365188 · Cited by 3
Bhartia, R. S. (2014) · General Medicine Open Access · doi:10.4172/2327-5146.1000133 · Cited by 3
Bisphosphonate Related Osteonecrosis of the Jaw
Zavras, A. I. (2015) · Springer eBooks · doi:10.1007/978-3-319-17942-1_14 · Cited by 3
Wang, Q., Hu, M. Y., Zhang, Y., Pan, X., Tan, W., & Li, C. (2013) · PubMed · Cited by 3
Severe Cutaneous Adverse Reactions
Fernando, S. L. (2011) · InTech eBooks · doi:10.5772/24303 · Cited by 3
Genetics and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: What Have We Learned?
Dunn, J. P. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0136 · Cited by 3
Ingram, C. J. E., Ekong, R., Ansari‐Pour, N., Bradman, N., & Swallow, D. M. (2020) · The Pharmacogenomics Journal · doi:10.1038/s41397-020-0175-0 · Cited by 3
Erythema Multiforme, Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Daniel, B. S., Wheeler, L. R., & Murrell, D. F. (2019) · Wiley eBooks · doi:10.1002/9781119142812.ch66 · Cited by 3
Manson, L. E. N., Delwig, S. J., Drabbels, J. J. M., Touw, D. J., de Vries, A. P. J., Roelen, D. L., & Guchelaar, H. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1289015 · Cited by 3
Finlay, A. Y., & Smith, C. H. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch72 · Cited by 3
Who should support the costs of severe adverse drug reactions?
Roujeau, J., & Pallec, S. L. (2011) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098610396118 · Cited by 3
“Unfortunately, further investigations strongly suggested that such tests would be useful only for a very limited number of drugs in specific population groups [Lonjou et al. 2008].”
BackgroundSelf-citationTeyton, L. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.9454964.10254054 · Cited by 3
Tsukagoshi, E., Nakamura, R., Kaniwa, N., Sai, K., Kikura‐Hanajiri, R., Matsunaga, K., Abe, R., Asada, H., & Saito, Y. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00595 · Cited by 2
Jiao, S., Su, D., Si, S., Zhang, N., Qiao, Y.-W., & Yu, G. (2025) · The Journal of Dermatology · doi:10.1111/1346-8138.70063 · Cited by 2
Uric acid as a cardiorenal risk factor - ready for prime-time?
Patel, K. H. K., & Goldsmith, D. J. A. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12428 · Cited by 2
Pharmacogenetics of Adverse Drug Reactions
Pushpakom, S. P., & Pirmohamed, M. (2011) · Wiley eBooks · doi:10.1002/9780470975053.ch2 · Cited by 2
Cutaneous drug reactions with systemic features
Knowles, S. R., & Shear, N. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2003-7.00066-2 · Cited by 2
Александровна, Л. А., Духанин, А. С., Teplyuk, N. P., Shimanovsky, N. L., & Yudin, A. A. (2024) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv625526 · Cited by 2
Hypersensitivity Reactions to Non-Beta Lactam Antibiotics
Gelincik, A. A., & Demir, S. (2021) · Current Treatment Options in Allergy · doi:10.1007/s40521-021-00293-z · Cited by 2
The Immunogenetics of Cutaneous Drug Reactions
Khalili, N. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-92616-8_17 · Cited by 2
Duong, T. A., & Valeyrie‐Allanore, L. (2010) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(10)51461-3 · Cited by 2
Update on HLA-B*15:02 Allele Associated with Adverse Drug Reactions
Zhu, X., Luo, G., & Zheng, L. (2024) · Pharmacogenomics · doi:10.2217/pgs-2023-0173 · Cited by 2
Sun, Y., & Xi, Y. (2014) · InTech eBooks · doi:10.5772/57513 · Cited by 2
Sundy, J. S. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.07.012 · Cited by 2
Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis
Intong, L. R. A., Daniel, B. S., & Murrell, D. F. (2015) · Springer eBooks · doi:10.1007/978-3-662-45698-9_29 · Cited by 2
Atteintes bronchopulmonaires au cours des toxidermies graves
de Prost, N., Dessap, A. M., Valeyrie‐Allanore, L., & Maître, B. (2012) · Réanimation · doi:10.1007/s13546-012-0522-5 · Cited by 2
Pharmacogenetics of Adverse Drug Reactions
Turner, R. M., & Pirmohamed, M. (2015) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-319-15344-5_6 · Cited by 2
Dermatological Adverse Drug Reactions
Valeyrie‐Allanore, L., & Roujeau, J. (2014) · Wiley eBooks · doi:10.1002/9781118820186.ch32 · Cited by 2
Self-citationHe, Y., Chong, F. H. T., Lim, J., Lee, R. J. T., & Yap, C. W. (2013) · Molecular Informatics · doi:10.1002/minf.201200086 · Cited by 2
Exploratory Study on Biomarkers Associated with Severe Cutaneous Adverse Reactions
Kaniwa, N. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.255 · Cited by 2
Khunakornsiri, U., Konyoung, P., Kongpan, T., Kwangsukstid, S., Kanjanawart, S., & Tassaneeyakul, W. (2014) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร · Cited by 2
Saff, R. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48551-7.00001-8 · Cited by 2
Gan, K. B., Chong, K. S., Nawoor, A. D., Then, S., Murad, N. A. A., & Jamal, A. R. A. (2020) · IEEE Access · doi:10.1109/access.2020.3044562 · Cited by 2
“The genetic association between HLAB*58:01 and AHS has been validated in numerous Asian countries, including Taiwan, Thailand, China, Hong Kong, Japan, Korea and Europe [2], [4]−[15].”
BackgroundSmall Molecule/HLA Complexes Alter the Cellular Proteomic Content
Hò, G. T., Hiemisch, W., Pich, A., Matern, M., Gräser, L. S., Blasczyk, R., Bade‐Doeding, C., & Simper, G. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97373 · Cited by 2
DRUGS AS INDUCERS OF STEVENS-JOHNSON SYNDROME - TOXIC EPIDERMAL NECROLYSIS IN CHILDREN
Dyubkova, T. P., & Жерносек, В. Ф. (2014) · Health and Ecology Issues · doi:10.51523/2708-6011.2014-11-3-1 · Cited by 2
Středová, M., Salavec, M., & Bartlova, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-58592-0_7 · Cited by 2
Wu, X., Graf, W. D., Schmitt, F. C., Kurlemann, G., Kunz, W. S., Heers, M., Kasper, B. S., Hamer, H. M., Zhou, D., & Stefan, H. (2012) · Clinical Epileptology · doi:10.1007/s10309-012-0268-0 · Cited by 2
Pharmacogenetics begins to deliver on its promises
Li‐Wan‐Po, A. (2015) · BMJ · doi:10.1136/bmj.h5042 · Cited by 2
Dental therapeutic guideline adherence in Australia
Teoh, L. (2020) · Minerva Access (University of Melbourne) · Cited by 2
Nawoor, A. D. (2022) · Nottingham ePrints (University of Nottingham) · Cited by 2
Réactions cutanées aux médicaments
Roujeau, J., & Wolkenstein, P. (2008) · Dermatologie et Infections Sexuellement Transmissibles (6e édition)#R##N#Avec Ebooks · doi:10.1016/b978-2-294-74649-9.00022-2 · Cited by 2
Self-citationSevere drug eruptions revisited
Calbo, S. (2012) · Immunologic Research · doi:10.1007/s12026-012-8271-0 · Cited by 1
Immunopharmaco-genomics: future of clinical medicine
Ali, S. I., Rather, M. A., Sheikh, W. M., Nabi, S. U., Ganai, A., Altaf, M., Nath, S., Ahmad, S. B., Wani, I. A., & Bashir, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00007-5 · Cited by 1
Immunogenetics in the diagnosis of clinical disorders
Ash, D., & Roy, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90250-2.00012-1 · Cited by 1
Schwere kutane Arzneimittelreaktionen bei Kindern
Mockenhaupt, M. (2023) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-023-01753-3 · Cited by 1
“Zum Beispiel ließ sich der bei Han-Chinesen nachgewiesene hochsignifikante Zusammenhang von carbamazepininduzierter EN und HLA-B*1502 bei europäischen Patienten nicht bestätigen [12].”
BackgroundSelf-citationLi, Y., Wang, H.-W., Peng, H.-Y., Zhang, Z., Yao, Z., Meng, Y., & Yang, D. (2025) · Discover Oncology · doi:10.1007/s12672-025-02176-0 · Cited by 1
“It is more prevelant in Asian population [59] than in Caucasian cohorts [60, 61].”
Stevens-Johnson syndrome induced by allopurinol in a HLA-B*58:01 –negative patient
Shin, M., Lee, B., & Kang, N. (2025) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2025.13.4.171 · Cited by 1
The Role of In Vivo, In Vitro and Pharmacogenomic Diagnostic Approaches to Sulfonamide Allergy
Waldron, J. L., Krantz, M. S., Sukasem, C., & Norton, A. E. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.02.029 · Cited by 1
Yang, H., Xu, J., Zhang, J., Zhang, X., Jin, C., Dai, H., & Yang, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1775888 · Cited by 1
“…(Chen et al., 2017; Yun et al., 2011) lamotrigine (Borrelli et al., 2018; Hosohata et al., 2019; Qian et al., 2025) HLA-B*15:02; HLA-B*38:01/*38:11 (Lonjou et al., 2008) HLA-DRB1*04:05/DQB1*04:01/DQA1*03:03 (Ito et al., 2015) phenytoin (Borrelli et al., 2018; Hosohata et al., Han Chinese (Wang et…”
InfluentialZhou, Y., Huang, G., & Li, H. (2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2026.13202 · Cited by 1
“Lonjou et al (35) demonstrated that HLA‑”
Imunogenética das reacções alérgicas a fármacos
Santos, N., & Cernadas, J. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Carbamazepine and Its Structurally-Related Antiepileptics
Chung, W., Chung, W., Tsai, J.-J., & Chen, Y.-T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-283-4_14 · Cited by 1
Charli-Joseph, Y. V., Lima, G., Ramos-Bello, D., Aguilar, D., Orozco‐Topete, R., & Llorente, L. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1305-6 · Cited by 1
“For allopurinol-induced cases of SJS/ TEN a 100 % association with HLA-B*5801 could be demonstrated in a Han-Chinese population, whereas in the European population, the association was present in not more than 55 % [11, 15, 17].”
BackgroundUtilization of Genomic Biomarkers for Post-marketing Safety of Drugs
Kaniwa, N. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00230-4 · Cited by 1
Pharmacogenomics and Cutaneous Adverse Drug Reactions
Pan, R., Chen, C., & Chung, W. (2018) · Springer eBooks · doi:10.1007/978-981-13-1489-6_3 · Cited by 1
Treatment of Hyperuricemia in Gout
Pérez-Ruiz, F., & Herrero-Beites, A. M. (2014) · doi:10.1007/978-1-907673-67-2_4 · Cited by 1
Anticonvulsant Agents Used for Neuropathic Pain Including Trigeminal Neuralgia
Clark, G. T., & Teruel, A. (2012) · Wiley eBooks · doi:10.1002/9781118704851.ch6 · Cited by 1
Nakashima, H., Koike, K., Fukami, K., Kusumoto, T., Hazama, T., Matsumoto, T., Ueda, S., & Okuda, S. (2013) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.46.493 · Cited by 1
Reporte de caso clínico: síndrome de Stevens Johnson
Barrera, R. G. (2014) · Medicina · Cited by 1
Okuläre Oberfläche – nicht infektiös
Chronopoulos, A., Dietrich-Ntoukas, T., Heiligenhaus, A., Heinz, C., Messmer, E. M., Mockenhaupt, M., Pleyer, U., Rübsam, A., & Schlomberg, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-38419-6_4 · Cited by 1
Self-citationSíndromes de Stevens-Johnson y de Lyell
Hua, C., & Valeyrie‐Allanore, L. (2018) · EMC - Dermatología · doi:10.1016/s1761-2896(18)90892-7 · Cited by 1
Синдром Стивенса-Джонсона – токсический эпидермальный некролиз у детей : монография
Дюбкова, Т. П., & Жерносек, В. Ф. (2013) · Digital Library of the Belarusian State University (Belarusian State University) · Cited by 1
Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions
Pérez‐Sánchez, N., Jurado‐Escobar, R., Doña, I., Soriano-Gomis, V., Moreno, C., Bartra, J., Isidoro‐García, M., Torres, M. J., & Cornejo-García, J. A. (2019) · Current Treatment Options in Allergy · doi:10.1007/s40521-019-0199-3 · Cited by 1
Bardin, T., Nguyen, Q. D., Bui, T.-H.-N., Le, N. H., Nguyen, Q. D., Resche‐Rigon, M., & Do, M. D. (2019) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2019.02.012 · Cited by 1
Grassi, S., Bossi, G., Croci, G. A., & Brazzelli, V. (2019) · JAAD Case Reports · doi:10.1016/j.jdcr.2019.05.013 · Cited by 1
How Mechanism Knowledge Can Help to Management of Drug Hypersensitivity
Ariza, A., Fernández, T. D., Bogas, G., Torres, M. J., & Mayorga, C. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00244-0 · Cited by 1
Chronopoulos, A., Mockenhaupt, M., & Pleyer, U. (2021) · Springer eBooks · doi:10.1007/978-3-662-60399-4_15 · Cited by 1
Self-citationPharmacogenetics of Adverse Drug Reactions
Daly, A. K., Armstrong, M., & Pirmohamed, M. (2012) · Wiley eBooks · doi:10.1002/9781118116494.ch10 · Cited by 1
Duong, T. A., & Valeyrie‐Allanore, L. (2010) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(10)70497-9 · Cited by 1
Pharmacogenetics of Cutaneous Adverse Drug Reactions
Yip, V. L. M., & Pirmohamed, M. (2022) · Updates in clinical dermatology · doi:10.1007/978-3-031-09388-3_1 · Cited by 1
Yuliwulandari, R., Chaikledkaew, U., Prayuni, K., Zahroh, H., Mahasirimongkol, S., Turongkaravee, S., Jittikoon, J., Wattanapokayakit, S., & Patrinos, G. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-813382-8.00003-3 · Cited by 1
A Case Report of Phenytoin-Induced Stevens-Johnson Syndrome
Syedraja, K., Karthikeyan, U., & Tamilselvan, S. (2023) · International Journal of Research and Review · doi:10.52403/ijrr.20230523 · Cited by 1
Pharmacogenetics: A New Approach for the Selection of the Right Drug
Malhotra, H., Dabra, A., Preeti, P., Kaushik, P., Kamboj, A., & Gautam, R. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2302-1_3 · Cited by 1
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Melikoğlu, M., & Pala, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-15130-9_97 · Cited by 1
Personalized Medicine - New Perspectives
Zhan, X. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1000393 · Cited by 1
ACETAMINOPHEN-INDUCED TOXIC EPIDERMAL NECROLYSIS IN PEDIATRIC PATIENTS-A CASE SERIES
MEVADA, D., Chabhadiya, P., & Singh, A. P. (2024) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2024v16i7.48175 · Cited by 1
Stadler, P., Clanner-Engelshofen, B. M., Oppel, E. M., Summer, B., Kerl-French, K., Flaig, M. J., French, L. E., & Seegräber, M. (2024) · Die Dermatologie · doi:10.1007/s00105-024-05361-4 · Cited by 1
Khan, S. A., Singh, P., & Sherbaevna, S. R. (2025) · Biomédica · doi:10.7705/biomedica.7581 · Cited by 1
“The RegiSCAR findings demonstrated that HLA-B*15:02 is not a reliable biomarker for toxic epidermal necrolysis induced by carbamazepine, sulfamethoxazole, lamotrigine, or oxicam-type NSAID since it does not sufficiently explain the etiology of the disease in European populations (18,19).”
Merk, H. F. (2010) · Der Hautarzt · doi:10.1007/s00105-010-1944-5 · Cited by 1
Síndrome de Lyell: estudio histológico y análisis funcional de la superficie ocular
Conesa Hernández, E. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
El origen de los mapuches y su relación con otros amerindios según los genes HLA
Lozano‐Flores, C. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Дюбкова, Т. П., & Жерносек, В. Ф. (2014) · BSU Digital Library (Belarusian State University)
Roujeau, J. (2013) · Wiley eBooks · doi:10.1002/9781118497784.ch6
Self-citationManagement of Hyperuricemia and Gout
Newcombe, D. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4264-5_9
Immunology of Cutaneous Drug Eruptions
Dyer, J. A. (2015) · Springer eBooks · doi:10.1007/978-1-4471-6729-7_1
Predicting Drug Hypersensitivity Reactions: Mechanistic and Clinical Implications
Elzagallaai, A. A. (2011) · Scholarship@Western (Western University)
Dalle, S., Knowles, S. R., & Shear, N. H. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-171-4_22
“These findings were first demonstrated in a Han Chinese population, and subsequently confirmed in European and Japanese cohorts [52, 53].”
ResultDefining the Role of Anti-epileptic Pharmacogenetics in Psychiatric Drug Therapy
Dlugos, D., Buono, R. J., & Ferraro, T. N. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080601-03
Ueta, M. (2013) · Inflammation and Regeneration · doi:10.2492/inflammregen.33.249
Pharmacogenomics in Developing Asian Countries
Lim, J. S. L., Chew, S. C., & Chowbay, B. (2012) · Advances in microbial ecology · doi:10.1007/978-1-4614-2182-5_12
Toxic Epidermal Necrolysis Seen in a Human Immunodeficiency Virus Positive Pregnant Patient
Sulayman, H., Kwala, W., Aliyu, Z., Attia, R. S., & Bushi, M. (2015) · Sub-Saharan African Journal of Medicine · doi:10.4103/2384-5147.157437
重症薬疹(スティーブンス・ジョンソン症候群及び中毒性表皮壊死症)のゲノム薬理学
Saito, Y., Kaniwa, N., Tohkin, M., Kurose, K., & Hasegawa, R. (2009) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.40.57s
Hypersensitivity drug reactions
Thong, B. Y., & Blanca, M. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000079
Reacções Adversas Medicamentosas Cutâneas: Estado da Arte
Figueiredo, A. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Zimmermann, S. Y. (2016) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3611
Managing the Risks to Gain the Benefits
Keenan, R. T. (2012)
Biomarkers associated with severe cutaneous adverse reactions
Kaniwa, N., & Saito, Y. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841848570.055
A Modern View of the Pathogenesis of Allergy with Drug Etiology
Mavlyanov, I. R., Хамидович, А. А., Искандарович, М. З., & Abdullaev, B. (2016) · Journal of Life Sciences Research · doi:10.20448/journal.504/2016.3.4/504.3.50.56
Multifactorial Diseases with Immunological Involvement
Xiao, T., Chen, H., Gao, J., Wang, G., Cizenski, J. D., Gou, D., Menter, A., Zhao, L., Yan, R., Wu, Y., et al. (2016) · Springer eBooks · doi:10.1007/978-94-024-0902-4_10
The immunopathogenesis of drug hypersensitivity
Rive, C. M. (2016) · Murdoch University Research Portal
Metadata
- Authors
- Lonjou, C., Borot, N., Sekula, P., Ledger, N., Thomas, L., Halevy, S., Naldi, L., Bouwes-Bavinck, J.-N., Sidoroff, A., de Toma, C., Schumacher, M., Roujeau, J.-C., Hovnanian, A., & Mockenhaupt, M.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- University Medical Center Freiburg (DE)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Ben-Gurion University of the Negev (IL)
- University of Milan (IT)
- Leiden University Medical Center (NL)
- Innsbruck Medical University (AT)
- Université Paris-Est Créteil (FR)
- Corresponding author
- Roujeau, Jean-Claude
- Venue
- Pharmacogenetics and Genomics
- Published
- 2008-02
- Volume
- 18
- Issue
- 2
- Pages
- 99-107
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W2025161685
- Cited by
- 624
- References
- 28
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 23 · 2023: 26 · 2022: 29 · 2021: 34 · 2020: 23 · 2019: 31 · 2018: 36 · 2017: 40 · 2016: 26 · 2015: 48 · 2014: 43 · 2013: 43 · 2012: 40
- FWCI
- 33.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacogenetics and Genomics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- Stevens-Johnson syndrome, toxic epidermal necrolysis, HLA-B*58:01, HLA-B*15:02, allopurinol, sulfamethoxazole, lamotrigine, oxicams, drug-induced skin reaction, European populations, genetic susceptibility
- MeSH terms
- Adult, Aged, Base Sequence, Female, Humans, Male, Middle Aged, Stevens-Johnson Syndrome, HLA-B Antigens, DNA Primers, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.